Carfilzomib
CAS: 868540-17-4
Molecular Formula: C40H57N5O7
Molecular weight:719.9099
Appearance:white powder
Density: 1.162g/cm3
Boiling point:975.627°C
Flash point:543.84°C
Use :For use in patients with multiple myeloma who have received at least two prior therapies, including treatment with bortezomib and an immunomodulatory therapy (such as lenalidomide) and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Disclaimer: the information on this website is from the internet for reference only. Please refer to the actual instructions attached to the product and the final interpretation is owned by the company.
for: Product Quotation ( Product suppliers),COA (Certificate of Analysis), New Sales
Promotion,New Products,And any other assistance.
After send online enquiry, we will reply you as soon as possible, if not get any response on time please contact us by Tel or Email.
1. Email: sales@aushealthingredients.com
2. Tel: +86 592 5365887
3. WhatsApp: +86 189 6516 2351
4. Send enquiry online: